Marshall Wace’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$309K Buy
702,478
+107,068
+18% +$81.3K ﹤0.01% 2644
2025
Q4
$780K Buy
595,410
+382,744
+180% +$613K ﹤0.01% 2054
2025
Q3
$300K Buy
+212,666
New +$648K ﹤0.01% 2431
2022
Q4
Sell
-44,419
Closed -$579K 2941
2022
Q3
$579K Buy
44,419
+13,271
+43% +$163K ﹤0.01% 2659
2022
Q2
$427K Buy
31,148
+8,088
+35% +$107K ﹤0.01% 2871
2022
Q1
$315K Buy
23,060
+14,306
+163% +$189K ﹤0.01% 2951
2021
Q4
$125K Buy
+8,754
New +$121K ﹤0.01% 3326

Other funds holding BIOX

Marshall Wace's BIOX Position: Q1 2026 in Review

Marshall Wace increased its Bioceres Crop Solutions (BIOX) stake by 18% in Q1 2026, buying an estimated $81.3K and bringing the position to 702,478 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #2644.

Marshall Wace first reported a position in BIOX in Q4 2021 and has held it in 7 quarters since. The position peaked at $780K in Q4 2025. 32 funds tracked by Wall St. Rank hold BIOX as of Q1 2026.

  • Marshall Wace held 702,478 shares of Bioceres Crop Solutions worth $309K as of Q1 2026.
  • Marshall Wace bought 107,068 Bioceres Crop Solutions shares in Q1 2026, an estimated $81.3K.
  • Bioceres Crop Solutions made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2644 holding.
  • Marshall Wace first reported a position in Bioceres Crop Solutions in Q4 2021 and has held it in 7 quarters since.
  • Marshall Wace's Bioceres Crop Solutions position peaked at $780K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.